Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,017 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
James Huang CASIF CASI Pharmaceuticals, Inc. 13G/A 18% 3y
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. LRFC Logan Ridge Finance Corporation Common Stock 13D 8.7% 3y
Matrix Capital Management Company, LP AURA Aura Biosciences, Inc. 13D/A 14.1% 3y
Bitfury Top HoldCo B.V. CIFR Cipher Digital Inc. 13D/A 75.4% 3y
Chris Kemp ASTR Astra Space, Inc. Class A Common Stock 13D/A 9.3% 3y
Tassos Recachinas LLAP Terran Orbital Corporation 13D/A 8.4% 3y
Lind Global Fund II LP AUMN Golden Minerals Co 13G 9.9% 3y
Adam London ASTR Astra Space, Inc. Class A Common Stock 13D/A 9.4% 3y
JCP Investment Management, LLC FARM FARMER BROTHERS CO 13D/A 5.1% 3y
HELU CARLOS SLIM TALO Talos Energy Inc. 13G/A 10.8% 3y
Saba Capital Management, L.P. IGA Voya Global Advantage & Premium Opportunity Fund 13D/A 6.29% 3y
TCI FUND MANAGEMENT LTD CNI Canadian National Railway Co 13D/A 6.3% 3y
STILWELL JOSEPH WHLR Wheeler Real Estate Investment Trust, Inc. 13D/A 75.7% 3y
Abdiel Qualified Master Fund, LP APPN Appian Corp 13D/A 17.6% 3y
22NW Fund, LP FARM FARMER BROTHERS CO 13D/A 10.2% 3y
Alta Fundamental Advisers LLC MIST Milestone Pharmaceuticals Inc. 13D 5% 3y
Scott Stanford ASTR Astra Space, Inc. Class A Common Stock 13D/A 16.8% 3y
NOVO HOLDINGS A/S LVTX LAVA Therapeutics N.V. Ordinary Shares 13D/A 7.1% 3y
Harraden Circle Investments, LLC GCTS GCT Semiconductor Holding, Inc. 13G 9.28% 3y
Point72 Asset Management, L.P. KRRO Korro Bio, Inc. 13G 6.8% 3y
AstraZeneca PLC CLLS Cellectis S.A. 13D 22.4% 3y
Karpus Management, Inc. VKQ Invesco Municipal Trust 13G/A 4.33% 3y
BAILLIE GIFFORD & CO RDFN Redfin Corporation Common Stock 13G/A 0.02% 3y
Dapice Joshua J. AGIO Agios Pharmaceuticals, Inc. 13G 7.1% 3y
BAILLIE GIFFORD & CO FTCH Farfetch Limited Class A Ordinary Shares 13G/A 7.53% 3y
WELLINGTON MANAGEMENT GROUP LLP TSVT 2seventy bio, Inc. Common Stock 13G/A 1.59% 3y
RIVERSTONE HOLDINGS LLC VTLE Vital Energy, Inc. 13G 11.8% 3y
Karpus Management, Inc. GLST Global Star Acquisition, Inc. Class A Common Stock 13G/A 4.13% 3y
WELLINGTON MANAGEMENT GROUP LLP RUSHA Rush Enterprises Inc Tx 13G/A 10.05% 3y
Karpus Management, Inc. KTF Dws Municipal Income Trust 13G/A 1.79% 3y
WELLINGTON MANAGEMENT GROUP LLP SP SP Plus Corporation 13G/A 2.45% 3y
Karpus Management, Inc. VTN Invesco Trust for Investment Grade New York Municipals 13G/A 0.98% 3y
JANUS HENDERSON GROUP PLC SKIN SkinHealth Systems Inc. 13G/A 10.1% 3y
WELLINGTON MANAGEMENT GROUP LLP ACH Accendra Health Inc 13G/A 4.76% 3y
BAILLIE GIFFORD & CO NVCR NovoCure Ltd 13G/A 4.77% 3y
WELLINGTON MANAGEMENT GROUP LLP RVMD Revolution Medicines, Inc. 13G/A 12.99% 3y
Nantahala Capital Management, LLC RDNW RideNow Group, Inc. 13G/A 10.7% 3y
Dapice Joshua J. RVMD Revolution Medicines, Inc. 13G 6.2% 3y
First Trust Capital Management L.P. FEXD Fintech Ecosystem Development Corp. Class A Common Stock 13G/A 9.68% 3y
COMPASS GROUP LLC VTRU Vitru Limited Common Shares 13G/A 14.15% 3y
WELLINGTON MANAGEMENT GROUP LLP AGIO Agios Pharmaceuticals, Inc. 13G/A 3.95% 3y
John P. Szabo, Jr. GAIA Gaia, Inc 13G 9% 3y
Versant Venture Capital VI, L.P. BDTX Black Diamond Therapeutics, Inc. 13D/A 8.4% 3y
Versant Venture Capital VI, L.P. GLUE Monte Rosa Therapeutics, Inc. 13D/A 13.7% 3y
Versant Venture Capital VI, L.P. TPST Tempest Therapeutics, Inc. 13D/A 15.9% 3y
Versant Venture Capital VI, L.P. PASG Passage BIO, Inc. 13D/A 7.3% 3y
John P. Szabo, Jr. INVE INVE Technologies, Inc. 13G 8% 3y
TENOR CAPITAL MANAGEMENT Co., L.P. NOGN Nogin, Inc. Common Stock 13G 5.03% 3y
Jelena Puzovic ATER Aterian, Inc. 13G/A 0.07% 3y
Artisan Topco LP AVID Avid Technology Inc 13D/A 100% 3y